Biocept Inc logo

BIOC - Biocept Inc News Story

$4.36 -0.0  -0.7%

Last Trade - 16/04/21

Sector
Healthcare
Size
Micro Cap
Market Cap £42.3m
Enterprise Value £33.6m
Revenue £19.9m
Position in Universe 5515th / 6850

BUZZ-Biocept rises as cancer detection test shows improvement

Mon 5th October, 2020 3:04pm
** Shares of diagnostics co  BIOC.O  rise 4.1% to $4.74
    ** Co's test may provide more robust method for detecting
lung cancer spread in cerebrospinal fluid than standard cytology
- study  urn:newsml:reuters.com:*:nPnbttHnYa
    ** Cytology is study of individual cells of the body, mainly
used to diagnose cancer
    ** Study was conducted in patients with non-small cell lung
cancer
    ** Test improved detection of circulating tumor cells (CTC),
finding CTCs in 78% of cerebrospinal fluid samples - BIOC 
    ** Says standard cancer tests detected tumor cells in 55% of
samples
    ** Stock up ~66% YTD

 (Reporting By Mrinalika Roy in Bengaluru)
 ((mrinalika.roy@thomsonreuters.com; within U.S. +1 646 223
8780, outside U.S. +91 806749 8325;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.